Pharmaceutical IP leaders are moving to AI-driven, product-centered IP management because it shortens decision cycles, reduces manual work, and protects revenue. This brief e-book explores current challenges and explains how new approaches and pharmaceutical-specific IP capabilities are boosting productivity and business insights for IP teams.
ほかも読む
ホワイトペーパー
知財ビジネス管理| 知財戦略
